Introduction to Biological and Small Molecule Drug Research and Development

- Theory and Case Studies

Forfatter: info mangler
Bog
  • Format
  • Bog, hardback
  • Engelsk

Beskrivelse

Introduction to Biological and Small Molecule Drug Research and Development provides, for the first time, an introduction to the science behind successful pharmaceutical research and development programs. The book explains basic principles, then compares and contrasts approaches to both biopharmaceuticals (proteins) and small molecule drugs, presenting an overview of the business and management issues of these approaches. The latter part of the book provides carefully selected real-life case studies illustrating how the theory presented in the first part of the book is actually put into practice. Studies include Herceptin/T-DM1, erythropoietin (Epogen/Eprex/NeoRecormon), anti-HIV protease inhibitor Darunavir, and more. Introduction to Biological and Small Molecule Drug Research and Development is intended for late-stage undergraduates or postgraduates studying chemistry (at the biology interface), biochemistry, medicine, pharmacy, medicine, or allied subjects. The book is also useful in a wide variety of science degree courses, in post-graduate taught material (Masters and PhD), and as basic background reading for scientists in the pharmaceutical industry.

Læs hele beskrivelsen
Detaljer
Størrelse og vægt
  • Vægt1120 g
  • coffee cup img
    10 cm
    book img
    19,1 cm
    23,5 cm

    Findes i disse kategorier...

    Se andre, der handler om...

    Distribution Cancer India Russia Brazil Chemistry Cost Decentralization Cytokines Cholesterol Biomolecules Biotechnology Bioinformatics Biopharmaceuticals Drug Discovery Epigenetics Absorption Chorus Chronic kidney disease Antigenicity Cyclin-dependent kinase (CdK) Age related macular degeneration (AMD) Biologics Biopharmaceutical Chronic Kidney Disease CKD Adenosine triphosphate (ATP) Enzyme replacement therapy Efficacy Attrition Acquired Immunodeficiency Syndrome (AIDS) Anaemia 3-4 Contract research organization (CRO) 4-(N-maleimidomethyl) cyclohexane-1-carboxylate (MCC) 5-Dimethylthiazol-2-yl)-2 5-diphenyltetrazolium bromide 5'-monophosphate (cyclic-AMP) 5'-monophosphate (cyclic GMP) Abciximab 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) Adapter protein involved in signal transduction (GRB2) Adenosine/guanosine triphosphate (A/GTP) Active-to-hit Acetylcholine (receptor) (ACh(R)) Adrenergic-G protein receptor complex Agonist/antagonist Amyloid beta precursor (APPI) Alpha-glucosidase (GAA) Angiotensin cleaving enzyme (ACE) and China (BRIC) Antidrug antibodies (ADAs) Antidrug antibody (ADA) Anti-erythropoietin antibodies (Anti-Epo Abs) Amprenavir (APV) Allosteric enzyme inhibitor Antibody-antigen binding fragment (FAb) Antibody-dependent cellular cytotoxicity (ADCC) Antibody-dependent cellular phagocytosis (ADCP) Biologics license application (BLA) Biosimilars/follow-on biologics Area under the curve (AUC) Biologics Price Competition and Innovation Act (BPCIA) biomolecular drugs Cell culture inhibitor concentration at >95% inhibition (CIC95) Chinese hamster ovary (CHO) cells Chronic myeloid leukaemia (CML) Calculated log P (c log P) Clearance (Cl) Coadministration of a PI with low-dose ritonavir (/r) Centres of Excellence in Drug Discovery (CEDDs) Chaperone therapy Complementarity determining regions (CDRs) Composer program Beta-sheet Candidate drug (CD) Colony-forming unit-erythroid (CFU-E) Catechol O-methyl transferase (COMT) Complementarity-determining region (CDR) Chinese hamster ovary (CHO) Cyclic guanosine -3' Chronic granulomatous disease (CGD) Chronic immune thrombocytopenia (ITP) Constant region (C) Dipeptidyl peptidase-4 inhibitor (DPP4i) Deoxyribonucleic acid (DNA) CREB-binding protein (CBP) Drug metabolism and pharmacokinetic (DMPK) compound annual growth rate (CAGR) Endoplasmic reticulum (ER) Epo gene (EPO) Erythrocytic progenitors Erythropoietin (Epo) Diethylstilbestrol (DES) Chimeric Mab D/L amino acids Dopamine (DA) Dual specificity kinase that phosphorylates ERK1 and 2 (MEK-1) Co-enzyme Enzyme active/binding/catalytic sites Epidermal growth factor receptor (HER1) Erythroid stimulating agent (ESA) Erythropoiesis-stimulating agent (ESA) Combined hormone replacement therapy (cHRT) Cluster of differentiation (CD) Enzyme cofactor Enzyme replacement therapy (ERT) Epidermal growth factor receptor 2 (ErbB2) Epidermal growth factor receptor 2 (HER2) Epidermal growth factor receptor (ErbB1) Epidermal growth factor receptor tyrosine kinase (EGFRTK) Conjugated equine oestrogen (CEE) Constant of inhibition (K Epidermal growth factor receptor (EGFR or ErbB-1) Eptifibatide Crohn's Disease (CD) Cyclic adenosine-3' cyclooxygenase (COX) Cryopyrin-associated periodic syndrome (CAPS) Darunavir (DRV) Designed ankyrin repeat protein (DARPin) Design-make-test (DMT) Domain antibody (dAb) Enzyme denaturation Erythropoietin receptor (Epo-R) Erythropoietin-mimetic peptides Enzyme classification (EC) epidermal growth factor (EGF) Epidermal growth factor receptor (EGFR) manufacturing and control (regulation) (CMC) (recombinant) Polyethylene glycol (rPEG) metabolism & elimination (ADME) (recombinant) Human growth hormone ((r)hGH)

    Velkommen til Saxo – din danske boghandel

    Hos os kan du handle som gæst, Saxo-bruger eller Saxo-medlem – du bestemmer selv. Skulle du få brug for hjælp, sidder vores kundeservice-team klar ved både telefonerne og tasterne.

    Om medlemspriser hos Saxo

    For at købe bøger til medlemspris skal du være medlem af Saxo Premium, Saxo Shopping eller Saxo Ung. De første 7 dage er gratis for nye medlemmer. Medlemskabet fornyes automatisk og kan altid opsiges. Læs mere om fordelene ved vores forskellige medlemskaber her.

    Machine Name: SAXO082